(Q41418008)

30 September 2017

1 reference

title

Overview of the safety of newer antiepileptic drugs (English)

1 reference

30 September 2017

S Shorvon

1

1 reference

30 September 2017

H Stefan

series ordinal

2

1 reference

30 September 2017

publication date

1 January 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

38 Suppl 1

1 reference

30 September 2017

page(s)

S45-51

1 reference

Pentylenetetrazol-induced seizures decrease gamma-aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Leucopenia associated with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Clinical use of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Neuropathology of vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

MRI findings in epileptic patients on vigabatrin for more than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Retrospective study of vigabatrin and psychiatric behavioural disturbances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Vigabatrin and behaviour disorders: a retrospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Interaction between vigabatrin and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Vigabatrin in the treatment of epilepsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Bilateral Hippocampal Atrophy in Medial Temporal Lobe Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

Thrombocytopenia in association with adjunctive felbamate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1997.TB04519.X

10.1111/J.1528-1157.1997.TB04519.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference